Ekos Release: Acute Pulmonary Embolism Trial Confirms Safety And Efficacy Of Ultrasound Accelerated Endovascular Thrombolysis

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a BTG International group company (BTG plc (LSE: BTG)), notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63rd Annual Scientific Session and Exposition of the American College of Cardiology in Washington, DC in the United States. The results were presented by Dr. Gregory Piazza, MD, Staff Physician, Cardiovascular Division, Brigham and Women’s Hospital and Instructor of Medicine, Harvard Medical School.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC